Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / SPONSORED ADS
-
Total 13F shares
-
30,437,070
-
Share change
-
-84,491
-
Total reported value
-
$70,005,160
-
Price per share
-
$2.30
-
Number of holders
-
31
-
Value change
-
-$2,961,853
-
Number of buys
-
12
-
Number of sells
-
14
Institutional Holders of GRACELL BIOTECHNOLOGIES INC - SPONSORED ADS (GRCL) as of Q4 2022
As of 31 Dec 2022,
GRACELL BIOTECHNOLOGIES INC - SPONSORED ADS (GRCL) was held by
31 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
30,437,070 shares.
The largest 10 holders included
Temasek Holdings (Private) Ltd, ORBIMED ADVISORS LLC, EcoR1 Capital, LLC, Capital International, Inc./CA/, GREAT POINT PARTNERS LLC, FEDERATED HERMES, INC., BlackRock Inc., Vivo Capital, LLC, Schonfeld Strategic Advisors LLC, and CAPITAL INTERNATIONAL SARL.
This page lists
31
institutional shareholders reporting positions in this security
for the Q4 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.